Gene testing war looms for AstraZeneca heart drug
Gene testing is shaping up to be a marketing battleground for new blood thinners like AstraZeneca’s Brilinta, underscoring the power and limitations of genetics as a tool to predict medical outcomes.
Read more on Reuters via Yahoo! News